Corrigendum: A Novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.

[This corrects the article DOI: 10.3389/fgene.2022.

A novel transcription factor-based signature to predict prognosis and therapeutic response of hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) is one of the most common aggressive malignancies with increasing incidence worldwide. The oncogenic roles of transcription factors (TFs) were increasingly recognized in various cancers. This study aimed to develop a predicting signature based on TFs for the prognosis and treatment of HCC.